Active Ingredient(s):Abrocitinib FDA Approved: * January 14, 2022 Pharm Company: *PFIZER INC Category:Skin Care
Abrocitinib, sold under the brand name Cibinqo, is a Janus kinase inhibitor medication used for the treatment of atopic dermatitis (eczema). It was developed by Pfizer.
1 Medical uses
2 Side effects
3.1 Mechanism of action
5 Society and culture
5.1 Legal status
7 External links
Abrocitinib is indicated for the treatment of moderate-to-severe atopic dermatitis in ...
* May have multiple approval dates, manufacturers, or labelers.